A Decade Of Novel CDER Approvals, By The Numbers
Pink Sheet infographic illustrates new drug approval trends and highlights from the past decade at the US FDA.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Tropical diseases were not neglected by the Center for Biologics Evaluation and Research in 2019, producing three novel vaccines (which earned three priority review vouchers) and tilting the approval class toward expedited review programs.